Epidemiology and characteristics of urinary tract infections in children and adolescents

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue MAY, 2015, Pages

  Hanna Wakim, Rima H ^a   Ghanem, Soha T ^b   El Helou, Mona W ^a   Khafaja, Sarah A ^a   Shaker, Rouba A ^a   Hassan, Sara A ^a   Saad, Randa K ^a   Hedari, Carine P ^a   Khinkarly, Rima W ^a   Hajar, Farah M ^b   Bakhash, Marwan ^a   El Karah, Dima ^a   Akel, Imad S ^a   Rajab, Mariam A ^b   Khoury, Mireille ^a   Dbaibo, Ghassan S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b MAKASSED GENERAL HOSPITAL   (Lebanon)

Author keywords

Antibiotic resistance; Children; ESBL; Risk factors; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAPENEM; CEPHALOSPORIN; ESTERASE; GENTAMICIN; GLYCOPEPTIDE; NITRITE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SUCCIMER; BETA LACTAMASE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; COHORT ANALYSIS; ECHOGRAPHY; ENTEROBACTER; ENTEROCOCCUS; ENURESIS; ESCHERICHIA COLI; FEMALE; GENDER; HUMAN; ICD-9; KLEBSIELLA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROTEUS; PSEUDOMONAS; PYELONEPHRITIS; RETROSPECTIVE STUDY; RISK FACTOR; URINALYSIS; URINARY TRACT INFECTION; UROLOGIC SURGERY; VESICOURETERAL REFLUX; ANIMAL; BACTERIUM; CLASSIFICATION; CLINICAL TRIAL; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SECRETION (PROCESS); URINARY TRACT INFECTIONS;

ADOLESCENT; ANIMALS; BACTERIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 85006190488     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2015.00045     Document Type: Article

References (33)

1. Al-Assil, B., Mahfoud, M., and Hamzeh, A. R. (2013). Resistance trends and risk factors of extended spectrum beta-lactamases in Escherichia coli infections in Aleppo, Syria. Am. J. Infect. Control 41, 597-600. doi: 10.1016/j.ajic.2012.09.016
2. Araj, G. F., Avedissian, A. Z., Ayyash, N. S., Bey, H. A., El Asmar, R. G., Hammoud, R. Z., et al. (2012). A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade. J. Med. Liban. 60, 125-135.
3. Ben-Ami, R., Rodriguez-Bano, J., Arslan, H., Pitout, J. D., Quentin, C., Calbo, E. S., et al. (2009). A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49, 682-690. doi: 10.1086/604713
4. Brown, P., Ki, M., and Foxman, B. (2005). Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy. Pharmacoeconomics 23, 1123-1142. doi: 10.2165/00019053-200523110-00005
5. Calbo, E., Romaní, V., Xercavins, M., Gómez, L., Vidal, C. G., Quintana, S., et al. (2006). Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J. Antimicrob. Chemother. 57, 780-783. doi: 10.1093/jac/dkl035
6. Circumcision, T. F. O. (1999). Circumcision policy statement. Pediatrics 103, 686-693. doi: 10.1542/peds.103.3.686
7. Daoud, Z., and Afif, C. (2011). Escherichia coli isolated from urinary tract infections of lebanese patients between 2000 and 2009: epidemiology and profiles of resistance. Chemother. Res. Pract. 2011:218431. doi: 10.1155/2011/218431
8. Dayan, N., Dabbah, H., Weissman, I., Aga, I., Even, L., and Glikman, D. (2013). Urinary tract infections caused by community-acquired extended-spectrum beta-lactamase-producing and nonproducing bacteria: a comparative study. J. Pediatr. 163, 1417-1421. doi: 10.1016/j.jpeds.2013.06.078
9. Dipietro, M. A., Blane, C. E., and Zerin, J. M. (1997). Vesicoureteral reflux in older children: concordance of US and voiding cystourethrographic findings. Radiology 205, 821-822. doi: 10.1148/radiology.205.3.9393542
10. Dotis, J., Printza, N., Marneri, A., Gidaris, D., and Papachristou, F. (2013). Urinary tract infections caused by extended-spectrum betalactamase-producing bacteria in children: a matched casecontrol study. Turk. J. Pediatr. 55, 571-574.
11. Edlin, R. S., Shapiro, D. J., Hersh, A. L., and Copp, H. L. (2013). Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J. Urol. 190, 222-227. doi: 10.1016/j.juro.2013.01.069
12. Ena, J., Arjona, F., Martinez-Peinado, C., Lopez-Perezagua Mdel, M., and Amador, C. (2006). Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Urology 68, 1169-1174. doi: 10.1016/j.urology.2006.08.1075
13. Foxman, B. (2014). Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 28, 1-13. doi: 10.1016/j.idc.2013.09.003
14. Giardino, S., Bandettini, R., Perotti, M., Piaggio, G., Degl'innocenti, L., Sacco, R., et al. (2013). Gram-negative urinary tract infections and increasing isolation of ESBL-producing or ceftazidime-resistant strains in children: results from a single-centre survey. Infez. Med. 21, 29-33.
15. Hooton, T. M., Besser, R., Foxman, B., Fritsche, T. R., and Nicolle, L. E. (2004). Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin. Infect. Dis. 39, 75-80. doi: 10.1086/422145
16. Juliano, T. M., Stephany, H. A., Clayton, D. B., Thomas, J. C., Pope, J. C. T., Adams, M. C., et al. (2013). Incidence of abnormal imaging and recurrent pyelonephritis after first febrile urinary tract infection in children 2 to 24 months old. J. Urol. 190, 1505-1510. doi: 10.1016/j.juro.2013.01.049
17. Kanafani, Z. A., Mehio-Sibai, A., Araj, G. F., Kanaan, M., and Kanj, S. S. (2005). Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am. J. Infect. Control 33, 326-332. doi: 10.1016/j.ajic.2005.03.009
18. Kizilca, O., Siraneci, R., Yilmaz, A., Hatipoglu, N., Ozturk, E., Kiyak, A., et al. (2012). Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children. Pediatr. Int. 54, 858-862. doi: 10.1111/j.1442-200X.2012.03709.x
19. Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., and Fishman, N. O. (2001). Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32, 1162-1171. doi: 10.1086/319757
20. Mahant, S., Friedman, J., and Macarthur, C. (2002). Renal ultrasound findings and vesicoureteral reflux in children hospitalised with urinary tract infection. Arch. Dis. Child. 86, 419-420. doi: 10.1136/adc.86.6.419
21. Megged, O. (2014). Extended-spectrum beta-lactamase-producing bacteria causing community-acquired urinary tract infections in children. Pediatr. Nephrol. 29, 1583-1587. doi: 10.1007/s00467-014-2810-y
22. Nickel, J. C. (2007). Urinary tract infections and resistant bacteria: highlights of a symposium at the combined meeting of the 25th international congress of chemotherapy (ICC) and the 17th European congress of clinical microbiology and infectious diseases (ECCMID), March 31-April 3, 2007, Munich, Germany. Rev. Urol. 9, 78-80.
23. Nicolle, L. E. (2002). Urinary tract infection: traditional pharmacologic therapies. Am. J. Med. 113(Suppl. 1A), 35S-44S. doi: 10.1016/s0002-9343(02)01058-6
24. Pepin, J., Plamondon, M., Lacroix, C., and Alarie, I. (2009). Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec. Can. J. Infect. Dis. Med. Microbiol. 20, e163-e168.
25. Pitout, J. D., and Laupland, K. B. (2008). Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8, 159-166. doi: 10.1016/S1473-3099(08)70041-0
26. Pourakbari, B., Ferdosian, F., Mahmoudi, S., Teymuri, M., Sabouni, F., Heydari, H., et al. (2012). Increase resistant rates and ESBL production between E. coli isolates causing urinary tract infection in young patients from Iran. Braz. J. Microbiol. 43, 766-769. doi: 10.1590/S1517-83822012000200041
27. Roberts, K. B. (2011). Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128, 595-610. doi: 10.1542/peds.2011-1330
28. Ronald, A. R., Nicolle, L. E., Stamm, E., Krieger, J., Warren, J., Schaeffer, A., et al. (2001). Urinary tract infection in adults: research priorities and strategies. Int. J. Antimicrob. Agents 17, 343-348. doi: 10.1016/S0924-8579(01)00303-X
29. Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., et al. (2009). The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int. J. Antimicrob. Agents 34, 407-413. doi: 10.1016/j.ijantimicag.2009.04.012
30. Soraas, A., Sundsfjord, A., Sandven, I., Brunborg, C., and Jenum, P. A. (2013). Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae-a case-control study in a low prevalence country. PLoS ONE 8:e69581. doi: 10.1371/journal.pone.0069581
31. Stamm, W. E., and Norrby, S. R. (2001). Urinary tract infections: disease panorama and challenges. J. Infect. Dis. 183(Suppl. 1), S1-S4. doi: 10.1086/318850
32. Tan, C. K., Ulett, K. B., Steele, M., Benjamin, W. H. Jr., and Ulett, G. C. (2012). Prognostic value of semi-quantitative bacteruria counts in the diagnosis of group B streptococcus urinary tract infection: a 4-year retrospective study in adult patients. BMC Infect. Dis. 12:273. doi: 10.1186/1471-2334-12-273
33. Topaloglu, R., Er, I., Dogan, B. G., Bilginer, Y., Ozaltin, F., Besbas, N., et al. (2010). Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children. Pediatr. Nephrol. 25, 919-925. doi: 10.1007/s00467-009-1431-3